Evaluation of Low Dose Alpha-Interferon in Patients with Advanced Renal Cell Carcinoma

Closed

Phase

Accrual

100%

Published

Abbreviated Title

Evaluation of Low Dose Alpha-Interferon in Patients with Advanced Renal Cell Carcinoma

Activated

05/01/1991

Closed

05/01/1992

Publication Information Expand/Collapse

2017

Association between body mass index and cancer survival in a pooled analysis of 22 clinical trials

H Greenlee;J Unger;M Leblanc;S Ramsey;D Hershman Cancer Epidemiology Biomarkers & Prevention 2017 Jan;26(1):21-29; 2016 Dec 16. [Epub ahead of print]

PMid: PMID27986655 | PMC number: PMC5370550

2014

Association between BMI at treatment initiation and cancer survival across multiple SWOG trials

H Greenlee;J Unger;M Leblanc;D Hershman AACR Research International Conference on Frontiers on Cancer Research Prevention (Sept 28-Oct 1, 2014, New Orleans, LA; poster

1995

Evaluation of low dose alpha-interferon (roferon-A) in patients with advanced renal cell carcinoma: A Southwest Oncology Group study.

ME Marshall;M Wolf;ED Crawford;IM Thompson;R Flanigan;SP Balcerzak;FJ Meyers Cancer Biotherapy 10(3):205-209